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Abstract
Background: Xylitol chewing gum has been shown to reduce Streptococcus mutans levels and decay. Two studies
examined the presence and time course of salivary xylitol concentrations delivered via xylitol-containing pellet gum and
compared them to other xylitol-containing products.
Methods: A within-subjects design was used for both studies. Study 1, adults (N = 15) received three xylitol-containing
products (pellet gum (2.6 g), gummy bears (2.6 g), and commercially available stick gum (Koolerz, 3.0 g)); Study 2, a
second group of adults (N = 15) received three xylitol-containing products (pellet gum, gummy bears, and a 33% xylitol
syrup (2.67 g). For both studies subjects consumed one xylitol product per visit with a 7-day washout between each
product. A standardized protocol was followed for each product visit. Product order was randomly determined at the
initial visit. Saliva samples (0.5 mL to 1.0 mL) were collected at baseline and up to 10 time points (~16 min in length) after
product consumption initiated. Concentration of xylitol in saliva samples was analyzed using high-performance liquid
chromatography. Area under the curve (AUC) for determining the average xylitol concentration in saliva over the total
sampling period was calculated for each product.
Results: In both studies all three xylitol products (Study 1: pellet gum, gummy bears, and stick gum; Study 2: pellet gum,
gummy bears, and syrup) had similar time curves with two xylitol concentration peaks during the sampling period. Study
1 had its highest mean peaks at the 4 min sampling point while Study 2 had its highest mean peaks between 13 to 16
minutes. Salivary xylitol levels returned to baseline at about 18 minutes for all forms tested. Additionally, for both studies
the total AUC for the xylitol products were similar compared to the pellet gum (Study 1: pellet gum – 51.3 µg.min/mL,
gummy bears – 59.6 µg.min/mL, and stick gum – 46.4 µg.min/mL; Study 2: pellet gum – 63.0 µg.min/mL, gummy bears –
55.9 µg.min/mL, and syrup – 59.0 µg.min/mL).
Conclusion: The comparison method demonstrated high reliability and validity. In both studies other xylitol-containing
products had time curves and mean xylitol concentration peaks similar to xylitol pellet gum suggesting this test may be
a surrogate for longer studies comparing various products.
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Background
Xylitol, a naturally occurring sugar alcohol currently
approved for use in foods, pharmaceuticals and oral
health products in more than 35 countries has been
shown to reduce cariogenic bacteria and tooth decay [1-
5]; particularly delivered by either gum or lozenge [6].
Our previous studies [2,7] have reported on the mini-
mally effective dose and frequency of use of xylitol deliv-
ered via pellet chewing gum to reduce Streptococcus
mutans, a tooth decay pathogen. It is thought that xylitol's
significant anti-caries effect is a result of constant
S.mutans suppression [8] and alteration in virulence [9]
from frequent and chronic exposure to xylitol-containing
products. Although xylitol chewing gum is effective, new
innovative ways to deliver xylitol at clinically effective lev-
els are needed because chewing gum is neither safe, for the
very young, nor acceptable, in schools, in the U.S. [6].
Nevertheless, repeated long-term clinical studies of the
various xylitol vehicles are not feasible. Thus, the develop-
ment of a surrogate test of a xylitol delivery system is war-
ranted.
There have been two studies examining salivary xylitol
levels after the intake of various xylitol-containing prod-
ucts in children [10,11], and none in adults. Lif Holgerson
et al [10] determined salivary xylitol concentrations in
children (mean age 11.5 years) after using a variety of xyl-
itol-containing products (chewing gums, lozenges, can-
dies, rinse, and fluoride toothpaste). All products were
consumed in a single session with a brief rinse of distilled
water immediately following consumption and a 10 min
washout between xylitol products. It appears that saliva
was collected from the floor of the mouth with a pipette.
This resulted in recovering a large amount of the xylitol in
the product but the method lacks any fidelity to actual
conditions under which the oral flora is exposed to xylitol.
Furthermore, it was unclear if saliva was collected the
same way after consumption of the xylitol product. The
researchers found that the xylitol products elevated sali-
vary xylitol concentrations between eight to 16 minutes
after xylitol product use. Tapiainen et al [11], in a second
study, found salivary xylitol concentrations in preschool-
aged children were immediately elevated after chewing
gum or when a xylitol syrup was squirted into the mouth
with a syringe but were undetectable after 15 minutes.
Saliva was collected in a different manner depending on
the age of the child; under age 3 saliva was collected
directly from the mouth via a pipette while children age 4
and older spat through a funnel into test tubes. It is
unclear how and when saliva was collected during xylitol
administration in these children as the protocol is not
detailed. For both studies, salivary xylitol concentrations
were determined by enzymatic assay using a polyol dehy-
drogenase-based procedure (Boehringer Mannheim, Ger-
many). The assay has a detection limit of approximately
200 ng/mL.
This paper describes a valid and reliable method to com-
pare salivary xylitol concentrations during use of xylitol-
containing products using a standardized and powerful
method of chemical analysis, high performance liquid
chromatography (HPLC). HPLC is a method of separat-
ing, identifying, and quantifying compounds in a sample.
It has been used previously to measure xylitol and other
sugar alcohols in gum and confectionary products
[12,13]. For the HPLC assay, the lower limit of detection
of xylitol, using the standard curve, is 0.2 ng/mL. Validity
is the extent to which a test accurately measures the
desired phenomenon it is attempting to measure [14].
Reliability is the extent to which the test is in agreement,
where agreement may occur across two time periods (e.g.,
test-retest), between comparable forms of the same test,
between individual sections of a test, or among different
raters [15-17]. Two studies which address the presence
and time course of xylitol in saliva delivered via a variety
of xylitol-containing products are described. This paper
specifically examines the presence and time course (peak
and duration of detectable amounts) of xylitol concentra-
tions in saliva for xylitol chewing gum (pellet and stick
forms), xylitol gummy bear, and xylitol syrup; and com-
pares the total xylitol-saliva time course curve (area under
the curve) of xylitol pellet chewing gum to a commercially
available xylitol stick gum, xylitol gummy bear and xylitol
syrup.
Methods
Design
Two studies were conducted using a within-subjects
design for each study (See Figure 1).
Subjects
For Studies 1 and 2, subjects (N = 15 per study) were
recruited using advertising flyers and posters on the Uni-
versity of Washington, Seattle, WA campus. Potentially
interested subjects were asked to call or email to learn
more about the study. Subjects were screened using a list
of questions (by phone) or a questionnaire (by email) to
determine if they were eligible to participate. Subjects
were excluded if they were under 18 years old, in poor
health, had full or partial bridges, had implants, had phe-
nylketonuria, or regularly used xylitol products. Xylitol
use was determined by a food questionnaire that was
developed and used for our previous xylitol studies and
updated for these studies [2,7]. The food questionnaire
was administered to potential subjects during the screen-
ing process. Regular xylitol use was defined as greater than
3 times a day or for greater than 3 days. These parameters
were established because in our previous xylitol studies
[2,7], this frequency was below the effective daily thresh-BMC Oral Health 2008, 8:5 http://www.biomedcentral.com/1472-6831/8/5
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old. The Institutional Review Board of the University of
Washington approved these studies and the written
informed consent of the participants was obtained.
Eligible subjects were given a date and time for their initial
(first) visit and asked to refrain from consuming any xyli-
tol product 24 hours before their visit. Subjects received a
list of products to avoid before their study visits. Subjects
were also asked to refrain from eating or drinking (except
water) 1 h prior to the visit.
Procedures
General Procedures
At the initial (first) visit and subsequent visits, the above
eligibility criteria were confirmed and a baseline stimu-
lated saliva sample was collected. Subjects chewed paraf-
fin for 1 minute (swallowed after the 1st 30 seconds, then
allowed saliva to accumulate during the 2nd 30 seconds),
spit into chilled pre-labelled 50 mL conical tubes, and dis-
carded the paraffin. The tubes were placed on ice immedi-
ately after the collection. Subjects were eligible to
continue in the study if they provided at least 1 mL of
stimulated saliva at baseline of this first visit. After the
baseline sample was taken, subjects received 1 of 3 xylitol-
containing products. All subjects were tested with each of
the 3 products over a 3-week period (See Studies 1 and 2).
There was a 7-day washout between each product. The
order of the xylitol products was randomly determined for
each subject at this visit using a random number genera-
tor.
Study 1
For Study 1, after subjects provided a baseline saliva sam-
ple (described above), they consumed 1 of 3 xylitol prod-
ucts (xylitol pellet gum (2.56 g/visit in 3 pieces; Fennobon
Oy, Karkkila, Finland), xylitol gummy bears (2.6 g/visit in
2 pieces; Santa Cruz Nutritional formerly Harmony Foods
Corp, CA, U.S.), and xylitol stick gum (3.0 g/visit in 2
pieces; Koolerz, Hershey Foods, PA, U.S.) and gave saliva
samples several times over a 15 to 20 minute period.
Saliva samples were taken during stimulated (while using
the xylitol product) and unstimulated (not using the
product) time points. At each sampling time point, a min-
imum of 0.5 mL of saliva was collected.
For the xylitol pellet or xylitol stick gum visits, subjects
chewed the gum and swallowed normally, at 1 minute
they swallowed one last time, tilted their heads forward
slightly, and spat the accumulated saliva into the pre-
labelled 50 mL conical tube. This was repeated for sam-
pling time points (2, 3, 4, and 5 minutes). After the 5
minute time point, the gum was discarded and subjects sat
quietly with their heads hung, making minimal jaw and
facial movements to allow the saliva to accumulate. The
unstimulated saliva was collected at 7, 9, 11, 13, and 15
minutes post baseline.
For the gummy bear visit, subjects chewed and swallowed
gummy bears (2 bears) one at a time. Immediately after
consuming the first gummy bear, subjects swallowed one
last time, tilted their heads forward slightly, and spat the
accumulated saliva into the pre-labelled conical tube.
Subjects followed the same procedure for consuming the
second gummy bear. After the second gummy bear, sub-
jects sat quietly with their heads hung, making minimal
jaw and facial movements to allow the saliva to accumu-
late. The unstimulated saliva was collected at 4, 6, 8, 10,
12, 14, and 16 minutes post baseline.
Study 2
After subjects provided a baseline paraffin stimulated
saliva sample in the same manner as in Study 1, they con-
sumed 1 of 3 xylitol products (xylitol pellet gum (same
dose as Study 1), xylitol gummy bears (same dose as Study
1), and 33% xylitol syrup (2.67 g/visit in a single 8 ml
unit-dose applicator; formula available upon request) and
gave saliva samples several times over a 15–20 minute
period. As in Study 1 saliva samples were collected with a
minimum of 0.5 mL per sample.
Refer to Study 1 for the procedures for the xylitol pellet
gum and gummy bear visits. For the syrup visit, subjects
applied approximately half of the syrup from the single
use unit-dose applicator into each side of their mouths
between their teeth and cheek. They swished the syrup
around their teeth with their tongue before swallowing.
Immediately after consuming the syrup, subjects swal-
lowed one last time, tilted their head forward slightly, and
spat the accumulated saliva into the pre-labelled conical
tube. Subjects sat quietly with their heads hung, making
Within-subjects study design utilized for Studies 1 and 2 Figure 1
Within-subjects study design utilized for Studies 1 and 2.BMC Oral Health 2008, 8:5 http://www.biomedcentral.com/1472-6831/8/5
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minimal jaw and facial movements to allow the saliva to
accumulate. Unstimulated saliva was collected at 2, 4, 6,
8, 10, 12, 14, 16, and 18 minutes.
For both Studies 1 and 2, saliva samples were transferred
from the conical tubes to 1.5 mL Eppendorf tubes and fro-
zen at -20°C prior to HPLC analysis.
HPLC Analysis
High performance liquid chromatography (HPLC) was
used to analyze the saliva samples. Saliva samples were
treated as follows: 200 µL of the saliva sample was added
to 50 µL of 1 M NaOH in a sterile 1.7 mL Eppendorf tube.
To this, 50 µL of Mannitol (source) at 2 µg/mL was added
to each sample to act as an internal standard. The samples
were vortexed briefly and then pipetted into another tube
fitted with a 0.45 micron PTFE filter and a clean autosam-
pler vial. These samples were spun for 1 min at 2,000 rpm
at room temperature; the eluant was used for HPLC anal-
ysis of monosaccharides on a CarboMA1 column [18
(Dionex Corp., Sunnyvale, CA)], and using the conditions
listed below.
An ESA autosampler was used to inject 30 µL of sample
during the separation run; the run time for each separa-
tion was 20 min. Isocratic HPLC separation of sugars was
performed using degassed 500 mM NaOH as the eluant,
utilizing a flow rate of 0.4 mL/min. The sugars were
detected by a Pulsed Amperometric detector with the
high-sensitivity Model 5040 gold electrodes (ESA Coulo-
chem II electrochemical HPLC). In all cases, the pulse set-
ting was +50, +700, and -800 mV for 500, 540, and 540
ms, respectively [19]. All run data was downloaded and
analyzed using EZChrom software, version 2.0 (ESA,
Chelmsford, MA). All salivary xylitol concentration data
were expressed in µg/mL, but could be expressed in the
Systeme International (SI) unit (mmol/L) (e.g., 40 µg/mL
= 0.26 mmol/L).
Data Analysis
All data were imported into MS Excel and checked. The
mean (SD) xylitol concentration for each sampling point
(Studies 1 and 2) was calculated using SPSS v. 12.02
(SPSS, Chicago, IL). Reliability was determined by calcu-
lating the correlation (Pearson product moment) between
the xylitol chewing gum (pellet) and the other xylitol-con-
taining products. For both studies approximation of area
under the curve (AUC, µg.min/ml) for determining the
average xylitol concentration in saliva over the total sam-
pling period was calculated for each product using SAS/
ETS PROC EXPAND (SAS, Cary, NC) and compared to the
xylitol chewing gum (pellet) curve to determine validity of
the method using PROC MIXED (SAS, Cary, NC).
Results
Study 1
In Study 1, all three xylitol products (pellet gum, gummy
bears, and stick gum) had similar time curves with a
higher first peak concentration followed by a lower sec-
ond peak concentration during the sampling period (See
Figure 2). Table 1 shows the mean xylitol concentrations
for each xylitol product at designated sampling points.
The mean first peak was at 4 min (pellet gum – 10.2 µg/
mL; gummy bears – 10.9 µg/mL; and stick gum – 9.0 µg/
mL). The mean second peak was at 13 min (pellet gum –
6.4 µg/mL; stick gum -5.2 µg/mL), and at 14 min (gummy
bears – 5.7 µg/mL). The timing of the second peak
between the xylitol gums and gummy bears can be attrib-
uted to the sampling protocol. Total AUC for the two xyl-
itol-containing products did not differ significantly from
the pellet gum (pellet gum – 51.3 µg.min/mL, gummy
bears – 59.6 µg.min/mL, and stick gum – 46.4 µg.min/
mL; F(1, 28) = 0.16, p = 0.69). The correlation coefficient
(r2) between the mean xylitol concentrations at each time
point was 0.99 between the xylitol pellet chewing gum
and xylitol gummy bears and 0.99 between the pellet and
stick gum.
Study 2
In Study 2, the three xylitol products (pellet gum, gummy
bears, and syrup) had similar time curves with a higher
second peak concentration opposite to that of Study 1
(See Figure 3). Table 2 shows the mean xylitol concentra-
tions at designated sampling points. The mean first peak
was at 4 min (pellet gum – 8.2 µg/mL; gummy bears – 7.0
µg/mL) and at 6–8 min for syrup – 6.0 to 6.6 µg/mL. The
mean second peak was between 13–16 min (13 min for
pellet gum – 10.1 µg/mL; 14 min for gummy bears – 9.0
µg/mL; and 16 min for syrup -8.3 µg/mL). As in Study 1,
the differential timing of the second peak between the xyl-
itol products can be attributed to its different sampling
protocols. Total AUC for the two xylitol-containing prod-
ucts did not differ significantly from the pellet gum (pellet
gum – 63.0 µg.min/mL, gummy bears – 55.9 µg.min/mL,
and syrup – 59.0 µg.min/mL; F(1, 26) = 0.05, p = 0.83).
The correlation coefficient (r2) between the mean xylitol
concentrations at each time point was 0.99 between the
xylitol pellet chewing gum and gummy bears and was
0.96 between the pellet chewing gum and the syrup.
Discussion
The xylitol-containing products used in these studies were
either commercially available (pellet gum, stick gum) or
manufactured for another one of our studies (gummy
bears, syrup). Subjects were instructed to consume the
products as they normally would be consumed. For exam-
ple, all gum pieces were chewed together and gummy
bears were consumed one at a time.BMC Oral Health 2008, 8:5 http://www.biomedcentral.com/1472-6831/8/5
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Both studies showed that across all xylitol products xylitol
salivary levels increased with xylitol product consump-
tion. The xylitol amount (i.e., dose) consumed for each
xylitol-containing product was the same unit dose previ-
ously determined in our xylitol studies to reduce S. mutans
level when consumed 3 to 5 times per day [7].
Both studies showed that the other xylitol-containing
products were similar to xylitol-containing pellet chewing
gum ("the gold standard") in their level and time course
of salivary xylitol concentrations. This suggests that this
method is a valid way to measure xylitol concentration in
saliva. Furthermore, the other xylitol-containing products'
(gummy bears, xylitol stick gum, and xylitol syrup) mean
salivary xylitol concentrations across time were highly cor-
related to xylitol pellet chewing gum's salivary xylitol. This
suggests that this method is reliable.
Studies 1 and 2 concurred with the Lif Holgerson and
Tapiainen studies [10,11]: salivary xylitol concentrations
were elevated for a short period of time (less than 15 min-
utes) and then subsequently declined. Interestingly, the
salivary levels within our studies did not increase in a lin-
ear fashion but in a bimodal fashion. Both the Lif Holger-
son and Tapiainen studies [10,11] did not show a second
peak concentration. As previously mentioned, it is unclear
from the description of the Lif Holgerson and Tapiainen
studies of the specific protocols followed for saliva sam-
pling. Our study protocol was geared toward a "real life"
approach; subjects were instructed to consume the xylitol
products as they normally would. It is possible that the
two peaks demonstrated in the current studies were a
result of the protocol; i.e., sampling both stimulated (dur-
ing xylitol consumption) and unstimulated salivary levels
since all products sampled demonstrated this. In the Lif
Study 1: Comparison of salivary xylitol concentrations (µg/mL) after using xylitol-containing products (N = 15) Figure 2
Study 1: Comparison of salivary xylitol concentrations (µg/mL) after using xylitol-containing products (N = 15).BMC Oral Health 2008, 8:5 http://www.biomedcentral.com/1472-6831/8/5
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Holgerson study (Experiment A), saliva was collected after
consumption of the xylitol product (unstimulated saliva)
which would correspond with our unstimulated sampling
period, and from the floor of the mouth using a pipette.
This may be an artefact of the salivary collection system
and raises questions about the validity of this approach.
Additionally, in the Tapiainen study only one sample per
child was taken whereas in the current study repeated
samples were taken per subject. Finally, the limits of
detection between the current and cited studies were dif-
ferent. The HPLC analysis had a much lower level of
detection of xylitol (0.2 ng/mL) compared to the enzy-
matic assay (0.2 mg/L) used in the previous studies
[10,11].
Interestingly, Study 2 had xylitol salivary levels slightly
below Study 1 and had its highest mean peak concentra-
tion at the latter half of the sampling period compared to
Table 1: Study 1: Salivary xylitol concentrations ((µg/mL) over time; mean (SD)) after using xylitol-containing products (N = 15)
Time Pellet chewing gum 
3 pieces × 0.85
Gummy bear 2 
pieces × 1.3 g
Stick chewing 
gum 2 pieces × 1.5 g
Baseline 2.06 (0.74) 1.55 (0.53) 1.55 (0.39)
1 min 1.72 (0.86) 1st – 2.19 (1.11)
2nd – 3.30 (1.58)
2.06 (2.08)
2 min 3.54 (3.89) 2.24 (1.39) 2.96 (2.28)
3 min 2.07 (0.98) -------- 2.16 (1.10)
4 min 10.22 (3.65) 10.87 (2.18) 8.97 (3.03)
5 min 3.59 (2.88) 3.14 (1.30)
6 min ------------ 2.87 (1.56) ------------
7 min 1.75 (.47) --------- 1.60 (0.55)
8 min ------------ 1.42 (0.49) ------------
9 min 2.10 (1.07) --------- 2.15 (0.99)
10 min ------------ 1.90 (0.62) ------------
11 min 2.62 (2.25) ------------ 2.43 (0.62)
12 min ------------ 2.33 (0.96) ------------
13 min 6.37 (4.41) ------------ 5.18 (2.60)
14 min ------------ 5.66 (2.86) ------------
15 min 2.45 (1.65) ------------ 2.03 (0.67)
16 min ------------ 2.27 (0.76) ------------
Table 2: Study 2: Salivary xylitol concentrations ((µg/mL) over time; mean (SD)) after using xylitol-containing products (N = 15)
Time Pellet chewing gum 3 
pieces × 0.85
Gummy bear 2 
pieces × 1.3 g
Syrup 2.67 g
Baseline 2.02 (0.60) 2.19 (0.64) 2.01 (0.43)
1 min 1.61 (0.26) 1st – 1.66 (0.48)
2nd – 3.27 (0.96)
1.98 (0.73)
2 min 2.87 (1.35) 1.87 (0.60) 3.45 (1.76)
3 min 1.83 (1.00) -------- ------------
4 min 8.20 (4.20) 7.03 (4.00) 2.50 (1.47)
5 min 5.93 (3.91) ------------
6 min ------------ 4.96 (1.49) 6.01 (3.62)
7 min 1.73 (0.33) --------- ------------
8 min ------------ 1.66 (0.64) 6.61 (3.71)
9 min 2.54 (1.01) --------- ------------
10 min ------------ 2.15 (0.56) 1.98 (0.68)
11 min 3.69 (1.81) ------------ ------------
12 min ------------ 3.33 (0.83) 2.06 (0.37)
13 min 10.12 (3.15) ------------ ------------
14 min ------------ 8.97 (3.28) 3.51 (1.21)
15 min 2.40 (1.05) ------------ ------------
16 min ------------ 2.40 (0.97) 8.29 (3.54)
18 min ------------ ------------ 2.45 (0.95)BMC Oral Health 2008, 8:5 http://www.biomedcentral.com/1472-6831/8/5
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Study 1. It is unclear why Study 2 results showed the
reverse bimodal distribution of salivary xylitol levels. This
variation may have been due to the inherent differences of
another group of subjects used in Study 2.
Conclusion
This methodology can be useful for examining the sali-
vary concentration and time course of xylitol in other xyl-
itol-containing products and could serve as a surrogate for
longer and more expensive studies involving bacterial
level assessment or clinical trials involving a large number
of human subjects. For both studies, compared to the xyl-
itol pellet gum, the other xylitol-containing products
tested had similar time curves and mean xylitol concentra-
tion peaks. This suggests that the other xylitol products'
effects on bacterial levels and tooth decay should be sim-
ilar to the effects demonstrated with xylitol pellet gum
use.
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